Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 4Neoplasms 3Cardiovascular Diseases 2Urogenital Neoplasms 1Smoldering Multiple Myeloma 1Sarcoma 1Psoriasis 1Prostatic Neoplasms 1Precancerous Conditions 1Pain 1Osteoarthritis 1Monoclonal Gammopathy of Undetermined Significance 1Melanoma 1Lung Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hypertension 1Head and Neck Neoplasms 1Fatigue 1Diabetes Mellitus 1Depressive Disorder, Major 1Depression 1Colorectal Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms, Male 1Breast Carcinoma In Situ 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Arthralgia 1

Interventions

Darbepoetin alfa 2piperine 1fludarabine phosphate 1ferrous sulfate 1ferric gluconate 1Whole-Body Irradiation 1Urination 1Therapeutics 1Sucrose 1Rituximab 1Phenytoin 1Peripheral Blood Stem Cell Transplantation 1Oxycodone 1Mycophenolic Acid 1Morphine 1Methotrexate 1Methadone 1Metformin 1KW-2478 1Hsp90 inhibitor KU757 1Granulocyte Colony-Stimulating Factor 1Gene Expression Profiling 1Fentanyl 1Fatty Acids, Omega-3 1Epoetin Alfa 1Early Intervention, Educational 1Cyclosporine 1Curcumin 1Celecoxib 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Monoclonal Gammopathy of Undetermined Significance × Fatty Acids, Omega-3 × Clear all
NCT00899353 2013-12-12

Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM)

Marshall University

Phase 2 Terminated
16 enrolled 6 charts
LymphoidOther hematologic neoplasmPlasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡